Senior Director Merck & Co. Kenilworth, New Jersey
Join Nicole Buist and several authors in Poster Forum #4 in the Solution Center (Exhibit Halls 3 & 4) for a conversation about posters on the topic, “Advances in Sterile Formulation Design to Enable Novel Treatments”, that she is especially excited about.
M1330-02-11 Aseptic Spray Drying and Homogenization for the Manufacture of a Sterile Long-Acting Injectable (LAI) Formulation, Nagireddy Dumpa, Ph.D., SRI International
T1030-08-54 Evaluation of Glycerol and Sorbitol in Preventing Aggregation of Monoclonal Antibodies under Mechanical Stress, Min Chen, MS, University of Iowa
M0930-01-01 The Impact of Oxidative Modifications on the Bioavailability of Subcutaneously Administered Therapeutic Monoclonal Antibodies, Moustafa Abdelaziz, MS, University of Kansas
W0930-02-13 Continuous Manufacturing of Injectable Nanoemulsions: Methods and Characterization, Thomai (Mimi) Panagiotou, Ph.D., Delphi Scientific, LLC
M1230-09-60 Predicting the Stability of Lyophilized Formulations Containing a Monoclonal Antibody and Sucrose/Trehalose Using Solid-State NMR Spectroscopy, Rachana Sapkota, MS, Purdue University